2022 the Japanese Society of Medical Oncology Annual Meeting

Session information

Poster Session

[P61] Poster Session 61 Lung Cancer/Thoracic Cancer(ICI efficacy 2)

Mayuko Tokuda1, Maiko Niki1,2, Takashi Yokoi1,2, Taiichiro Otsuki1,2, Koji Mikami1,2, Eisuke Shibata1,2, Daisuke Horio1, Yoshiki Negi1, Akio Tada1, Jotaro Kiyota1, Misaki Morishita1, Toshiyuki Minami1,2, Ryo Takahashi1,2, Kozo Kuribayashi1,2, Takashi Kijima1,2 (1.Department of Respiratory Medicine and Hematology Hyogo College of Medicine, 2.Department of Thoracic Oncology Department of Thoracic Oncology)

Takayasu Kurata1, Patrick Cobb2, Melissa L. Johnson3, Lokesh Jain4, Sung Jin Kim4, Sanatan Saraf4, Mallika Lala4, Balazs Halmos5 (1.Department of Thoracic Oncology, Kansai Medical University Hospital, Osaka, Japan, 2.St. Vincent Frontier Cancer Center, SCL Health Research Institute, Inc., Billings, MT, USA, 3.Sarah Cannon Research Institute, Tennessee Oncology, PLLC, Nashville, TN, USA, 4.Merck & Co., Inc., Kenilworth, NJ, USA, 5.Department of Oncology, Montefiore Einstein Center for Cancer Care, New York, NY, USA)